Given the significance of immune checkpoint inhibitor-based immunotherapy, the expression levels of five common immune checkpoint molecules (CD274, BTLA, CD28, CTLA4, and PDCD1LG2) between the low-risk and high-risk subsets were compared to evaluate the responses of STAD patients to immunotherapy. Here, CD274 is linked to gastric adenocarcinoma.